Genomind is a leading medication management company focused on empowering healthcare providers in optimizing the treatment experience for their patients through actionable genetic insights and innovative health technology, reducing the guessing game in medication selection. Since its founding, Genomind has been a leader in pharmacogenetic testing, and continues to advance precision health services for individual and population-level patient care. Built on the foundation of compassionate care and clinical expertise, Genomind is empowering a more targeted and personalized approach to medication management in psychiatric care and beyond, to achieve a new standard of excellence.
Address:
2200 Renaissance Blvd, Suite 100, King of Prussia, PA, 19406
Website:
https://genomind.com/